4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000113
EVP Research and Development gave up 18,441 shares (to pay taxes)
- EVP Research and Development acquired 23,638 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAHL NEIL · EVP Research and Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-02 | Exercise or conversion : show line 1 in the form | +23,638 | $555.67 | $13,134,927 | 74,637 | D |
| 2024-08-02 | Shares withheld for taxes : show line 2 in the form | −18,441 | $1,093.49 | $20,165,049 | 56,196 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-02 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) | −23,638 | 45,000 | D |
Loading xslF345X05/edgardoc.xml…